Latest filing published 25 Sept 2018 for CEREBAIN BIOTECH CORP., €23k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Wesley D. Tate: trading record in brief
All filings by Wesley D. Tate on record concern Cerebain Biotech Corp. In total, 6 filings cover trades dated from 16 June 2014 to 19 February 2018.
Every open-market trade on record is a purchase: 2 purchases worth €66k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.
Most recently, on 25 September 2018, the filings show a share grant worth €23k in Cerebain Biotech Corp. The clock since the last published purchase (27 June 2014) now reads 4,517 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Wesley D. Tate
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 160,000 shares@ US$0.18100.0% of flowCommon StockSEC:0001435164-18-000001:0
- 150,000 shares@ US$0.2736.3% of flowCommon StockSEC:0001582945-16-000010:0
- 150,000 shares@ US$0.3040.8% of flowCommon StockSEC:0001582945-16-000010:1
- 47,203 shares@ US$1.10Common StockSEC:0001435164-14-000001:0Canonical exit: 14 Sept 2014 (T+90)
- 25,000 shares@ US$1.50Common StockSEC:0001435164-14-000001:1Canonical exit: 14 Sept 2014 (T+90)
5 of 5 declarations